PARD6A

PARD6A
Identifiers
AliasesPARD6A, PAR-6A, PAR6, PAR6C, PAR6alpha, TAX40, TIP-40, par-6 family cell polarity regulator alpha
External IDsOMIM: 607484; MGI: 1927223; GeneCards: PARD6A
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001037281
NM_016948

NM_001047435
NM_001047436
NM_001286344
NM_001286345
NM_019695

RefSeq (protein)

NP_001032358
NP_058644

NP_001040900
NP_001040901
NP_001273273
NP_001273274
NP_062669

Location (UCSC)Chr 16: 67.66 – 67.66 MbChr 8: 106.43 – 106.43 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Partitioning defective 6 homolog alpha is a protein that in humans is encoded by the PARD6A gene.

Function

This gene is a member of the PAR6 family and encodes a protein with a PSD95/Discs-large/ZO1 (PDZ) domain and a semi-Cdc42/Rac interactive binding (CRIB) domain. This cell membrane protein is involved in asymmetrical cell division and cell polarization processes as a member of a multi-protein complex. The protein also has a role in the epithelial-to-mesenchymal transition (EMT) that characterizes the invasive phenotype associated with metastatic carcinomas. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

A recent study shows that Par6 associates with PKC-ι but not with PKC-zeta in melanoma. Oncogenic PKC-iota can promote melanoma cell invasion by up-regulating PKC-ι/Par6 pathway during EMT. PKC-ι inhibition or knockdown resulted an increase E-cadherin and RhoA levels while decreasing total Vimentin, phophorylated Vimentin (S39) and Par6 in metastatic melanoma cells. These results suggested that PKC-ι is involved in signaling pathways which upregulate EMT in melanoma.

Interactions

PARD6A has been shown to interact with: